These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Apolipoproteins, the lipid hypothesis and ischaemic heart disease. Avogaro P Przegl Lek; 1985; 42(8):602-6. PubMed ID: 4089215 [No Abstract] [Full Text] [Related]
6. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke. Kostner GM; Marth E; Pfeiffer KH; Wege H Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549 [No Abstract] [Full Text] [Related]
7. Structure and function of plasma lipoproteins with particular regard to hyperlipoproteinemias and atherosclerosis. Alaupovic P Ann Biol Clin (Paris); 1980; 38(2):83-93. PubMed ID: 6992659 [No Abstract] [Full Text] [Related]
9. [Apolipoproteins as risk factors of atherosclerosis]. Dargel R; Winkler L Z Med Lab Diagn; 1989; 30(1):35-6. PubMed ID: 2718575 [No Abstract] [Full Text] [Related]
10. High-density lipoproteins and the risk of atherosclerosis. Lees RS; Lees AM N Engl J Med; 1982 Jun; 306(25):1546-8. PubMed ID: 7078610 [No Abstract] [Full Text] [Related]
11. Simultaneous measurement of plasma apolipoproteins A-I and B by electroimmunoassay. Fruchart JC; Kora I; Cachera C; Clavey V; Duthilleul P; Moschetto Y Clin Chem; 1982 Jan; 28(1):59-62. PubMed ID: 6799226 [TBL] [Abstract][Full Text] [Related]
12. [Determination of apolipoproteins AI and B: diagnostic significance and immunochemical methods]. Marcovina S Ric Clin Lab; 1984; 14 Suppl 2():75-94. PubMed ID: 6442453 [No Abstract] [Full Text] [Related]
13. [Apolipoproteins: valuable indicators of atherogenicity in patients with coronary disease and normal blood lipids]. Mordasini R; Riesen W Ann Med Interne (Paris); 1983; 134(5):479-82. PubMed ID: 6418049 [TBL] [Abstract][Full Text] [Related]
14. [Blood screening for the first markers of atherosclerosis. Diagnostic progress and therapeutic perspectives]. Malmendier CL Bull Mem Acad R Med Belg; 1987; 142(1):168-74. PubMed ID: 3311257 [No Abstract] [Full Text] [Related]
15. [The determination of apolipoproteins. Its possible diagnostic importance]. Titov VN; Tvorogova MG Ter Arkh; 1992; 64(6):115-9. PubMed ID: 1440326 [No Abstract] [Full Text] [Related]
16. Lipid risk factors and atherosclerosis: what do we measure? Stein EA Scand J Clin Lab Invest Suppl; 1990; 198():3-8. PubMed ID: 2189208 [TBL] [Abstract][Full Text] [Related]
17. Review of serum lipids and apolipoproteins in risk-assessment of coronary heart disease. Rifai N; Chapman JF; Silverman LM; Gwynnes JT Ann Clin Lab Sci; 1988; 18(6):429-39. PubMed ID: 3071240 [TBL] [Abstract][Full Text] [Related]
18. The relation of diet to atherosclerosis. ALBRINK MJ; MAN EB Conn State Med J; 1956 Dec; 20(12):974-81. PubMed ID: 13375105 [No Abstract] [Full Text] [Related]
19. [Immunochemical study of the alpha 2-glycoprotein from the atherosclerotically altered aortic wall in the blood serum of ischemic heart disease patients]. Murashko VV; Baranov AP; Kamenets AV; Tatarinov IuS; Chekhonin VP Ter Arkh; 1985; 57(9):37-9. PubMed ID: 2417347 [TBL] [Abstract][Full Text] [Related]
20. [Will apoproteins dethrone lipids in the study of the etiology of atherosclerosis and other diseases?]. Malmendier CL Bull Mem Acad R Med Belg; 1983; 138(3):215-24. PubMed ID: 6360271 [No Abstract] [Full Text] [Related] [Next] [New Search]